)
Janaiah Kota
Executive Director, Molecular Therapeutics,
Ultragenyx
Dr. Janaiah Kota is a biomedical researcher and gene therapy expert with extensive experience in adeno-associated virus (AAV) gene therapy and RNAi therapeutics. As Executive Director of Molecular Therapeutics at Ultragenyx, he leads the development of innovative genetic medicines for rare diseases.
He completed his postdoctoral fellowship in gene therapy at Nationwide Children's Hospital (2006–2011) and has authored multiple peer-reviewed publications and holds several patents with real-world clinical impact. Dr. Kota brings a deep skill set in genetics, molecular biology, cancer research, and molecular cloning, and is recognized for his contributions to advancing the field of genetic therapeutics.
Sessions